A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive ...

Mighty Therapeutics and the University of Washington will use pilot data on elamipretide to design a larger trial in older ...

Lovehoney’s hormone-free MenoPulse device launches, pairing air-pulse tech with early data on symptoms and autonomic function ...

QIMA Life Sciences launches SQINGEVITY, bringing biological testing and clinical studies together to examine claims about ...

Forecast for rapid growth by 2033, with disease-modifying therapies driving sales – and healthcare systems confronting the cost of access.

Small open-label study of ATR-258 saw fat loss, lean mass gains and better leg power, but no placebo group and just eight ...

Better U and Evernow have joined forces to pair menopause specialists with psychiatry in a nationwide telehealth service.

Arvinas presented early biomarker data on ARV-102, an oral drug built to clear the LRRK2 protein, at a major Parkinson’s ...

A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...

GPX4-targeting therapy reduces epigenetic age markers and circulating inflammation, raising questions about effects beyond ...

Ascensia partnership puts the London healthtech’s microsensor on the road to a European launch – with ambitions that run well ...

Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data ...